Product Description: Entecavir monohydrate (BMS200475 monohydrate; SQ34676 monohydrate) is a potent and selective inhibitor of HBV, with an EC50 of 3.75 nM in HepG2 cell.
Applications: COVID-19-anti-virus
Formula: C12H17N5O4
References: [1]Innaimo SF, et al. Identification of?BMS-200475?as a potent and selective inhibitor of hepatitis B virus. Antimicrob Agents Chemother. 1997 Jul;41(7):1444-8./[2]Rivkin A, et al. A review of entecavir in the treatment of chronic hepatitis B infection. Curr Med Res Opin.?2005 Nov;21(11):1845-56./[3]Genovesi EV, et al. Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside?BMS-200475?in the woodchuck model of hepatitis B virus infection. Antimicrob Agents Chemother.?1998 Dec;42(12):3209-17.
CAS Number: 209216-23-9
Molecular Weight: 295.29
Compound Purity: 99.95
Research Area: Infection; Cancer
Solubility: DMSO : ≥ 50 mg/mL/H2O : 2.8 mg/mL (ultrasonic;warming)
Target: HBV
Deutsch
English
